...
首页> 外文期刊>Neurogastroenterology and motility >Synergy between 5‐ HT HT 4 4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle
【24h】

Synergy between 5‐ HT HT 4 4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle

机译:5-HT 4 4受体刺激和磷酸二酯酶4之间的协同作用在人大肠循环中促进乙酰胆碱释放的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background Gastroprokinetic properties of 5‐ HT 4 receptor agonists, such as prucalopride, are attributed to activation of 5‐ HT 4 receptors on cholinergic nerves innervating smooth muscle in the gastrointestinal smooth muscle layer, increasing acetylcholine release and muscle contraction. In porcine stomach and colon, phosphodiesterase ( PDE ) 4 has been shown to control the signaling pathway of these 5‐ HT 4 receptors. The aim of this study was to investigate the PDE ‐mediated control of these 5‐ HT 4 receptors in human large intestine. Methods Circular smooth muscle strips were prepared from human large intestine; after incubation with [3H]‐choline, electrically induced tritium outflow was determined as a measure for acetylcholine release. The influence of PDE inhibition on the facilitating effect of prucalopride on electrically induced acetylcholine release was studied. Key Results The non‐selective PDE inhibitor IBMX enhanced the facilitating effect of prucalopride on electrically induced acetylcholine release. The selective inhibitors vinpocetine ( PDE 1), EHNA ( PDE 2) and cilostamide ( PDE 3) did not influence, while rolipram and roflumilast ( PDE 4) enhanced the prucalopride‐induced facilitation to the same extent as IBMX . Conclusions & Inferences In human large intestinal circular muscle, the intracellular pathway of 5‐ HT 4 receptors facilitating cholinergic neurotransmission to large intestinal circular smooth muscle is controlled by PDE 4. If the synergy between 5‐ HT 4 receptor agonism and PDE 4 inhibition is confirmed in a functional assay with electrically induced cholinergic contractions of human large intestinal circular smooth muscle strips, combination of a selective 5‐ HT 4 receptor agonist with a selective PDE 4 inhibitor might enhance the in vivo prokinetic effect of the 5‐ HT 4 receptor agonist in the large intestine.
机译:摘要背景下5-HT 4受体激动剂(如养化剂)的胃陷性能归因于胆碱能神经中的5-HT 4受体,在胃肠道平滑肌层中的平滑肌,增加乙酰胆碱释放和肌肉收缩。在猪胃和结肠中,已经证明了磷酸二酯酶(PDE)4来控制这些5-HT 4受体的信号通路。本研究的目的是探讨人类大肠中这些5-HT 4受体的PDE介导的控制。方法从人大肠中制备圆形平滑肌条;与[3H]孵育后 - 胆碱,电诱导的氚流出量被确定为乙酰胆碱释放的量度。研究了PDE抑制对肥华普通普照促进对电诱导的乙酰胆碱释放的影响。关键结果非选择性PDE抑制剂IBMX增强了肥华促进对电诱导的乙酰胆碱释放的促进作用。选择性抑制剂Vinpocetine(PDE 1),EHNA(PDE 2)和西霉素(PDE 3)没有影响,而Rolipram和Roflumilast(PDE 4)将腐植化诱导的促进剂增强至与IBMX相同的程度。结论&人类大肠循环肌的推论,5-HT 4受体的细胞内途径,促进胆碱能神经递送到大肠圆形光滑肌的肺部4.如果在a中确认了5-HT 4受体激动和PDE 4抑制之间的协同作用用电诱导人大肠圆形光滑肌条的电诱导的胆碱能收缩功能测定,选择性5-HT 4受体激动剂与选择性PDE 4抑制剂的组合可以增强大的5-HT 4受体激动剂的体内动脉效应肠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号